431 476
systematic review and meta-analysis of effectiveness and compli-
cations. Eur Urol 2014;65:402–27.
[27]
Pickard R, Reaper J, Wyness L, Cody DJ, McClinton S, N’Dow J. Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev 2003;2:CD003881.[28]
Aref-Adib M, Lamb BW, Lee HB, et al. Stem cell therapy for stress urinary incontinence: a systematic review in human subjects. Arch Gynecol Obstet 2013;288:1213–21.[29]
Biardeau X, Aharony S, AUS Consensus Group. Campeau L, Corcos J. Overview of the 2015 ICS Consensus Conference. Neurourol Urodyn 2016;35(4):437–43.[30]
Lucas MG, Bosch RJL, Burkhard FC, et al. Guı´a clı´nica de la Asocia- cio´ n Europea de Urologı´a sobre el tratamiento quiru´ rgico de la incontinencia urinaria. Acta Urol Esp 2013;37:459–72.[31]
Fritel X, Fauconnier A, Bader G, et al. Diagnosis and management of adult female stress urinary incontinence: guidelines for clinical practice from the French College of Gynaecologists and Obstetri- cians. Eur J Obstet Gynecol Reprod Biol 2010;151:14–9.
[32]
Hermieu J-F, Conquy S, Leriche B, et al. Synthe`se des recommanda- tions pour le traitement de l’incontinence urinaire fe´minine non neurologique. Prog Urol 2010;20:S94–9.
[33]
Miedel A, Ek M, Tegerstedt G, Mæhle-Schmidt M, Nyre´n O, Ham- marstro¨m M. Short-term natural history in women with symptoms indicative of pelvic organ prolapse. Int Urogynecol J 2011;22:461–8.[34]
Bradley CS, Zimmerman MB, Qi Y, Nygaard IE. Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol 2007;109:848–54.
[35]
Ismail SI, Bain C, Hagen S. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women. Cochrane Data- base Syst Rev 2010;9:CD007063.[36]
Hagen S, Stark D, Glazener C, et al. Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multi- centre randomised controlled trial. Lancet 2014;383:796–806.[37]
Bugge C, Adams EJ, Gopinath D, Reid F. Pessaries (mechanical devices) for pelvic organ prolapse in women. Cochrane Database Syst Rev 2013;2:CD004010.[38]
Chmielewski L, Walters MD, Weber AM, Barber MD. Reanalysis of a randomized trial of 3 techniques of anterior colporrhaphy using clinically relevant definitions of success. Am J Obstet Gynecol 2011;205:69.e1–8.[39]
Kapoor DS, Nemcova M, Pantazis K, Brockman P, Bombieri L, Freeman RM. Reoperation rate for traditional anterior vaginal repair: analysis of 207 cases with a median 4-year follow-up. Int Urogynecol J 2010;21:27–31.
[40]
Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Brown J. Surgery for women with apical vaginal prolapse. Cochrane Data- base Syst Rev 2016;10:CD012376.[41]
Glazener CM, Breeman S, Elders A, et al. Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT). Lancet 2017;389:381–92.[42]
Maher C, Feiner B, Baessler K, Schmid C. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2013;4:CD004014.[43]
Visco AG, Advincula AP. Robotic gynecologic surgery. Obstet Gyne- col 2008;112:1369–84.[44]
Mueller MG, Ellimootil C, Abernethy MG, Mueller ER, Hohmann S, Kenton K. Colpocleisis: a safe, minimally invasive option for pelvic organ prolapse. Female Pelvic Med Reconstr Surg 2015;21:30–3.[45]
Vij M, Bombieri L, Dua A, Freeman R. Long-term follow-up after colpocleisis: regret, bowel, and bladder function. Int Urogynecol J 2014;25:811–5.
[46]
Zebede S, Smith AL, Plowright LN, Hegde A, Aguilar VC, Davila GW. Obliterative LeFort colpocleisis in a large group of elderly women. Obstet Gynecol 2013;121(2 Part 1):279–84.[47]
Smith DB, Smith DB, Kelsey JF, et al. Laparoscopic uterine suspen- sion. J Reprod Med 1977;18:98–102.[48]
Poulhe´s J, Rieu JP, Becue J. Strip of skin for uterine suspension and vesical support. J Chir 1971;101:563–70.[49]
Ridley JH. A composite vaginal vault suspension using fascia lata. Am J Obstet Gynecol 1976;126:590–6.[50]
Ostrzenski A. Laparoscopic colposuspension for total vaginal pro- lapse. Int J Gynaecol Obstet 1996;55:147–52.[51]
Filmar GA, Fisher HW, Aranda E, Lotze PM. Laparoscopic uterosacral ligament suspension and sacral colpopexy: results and complica- tions. Int Urogynecol J 2014;25:1645–53.
[52]
Cunjian Y, Li L, Xiaowen W, Shengrong L, Hao X, Xiangqiong L. A retrospective analysis of the effectiveness of a modified abdominal high uterosacral colpopexy in the treatment of uterine prolapse. Cell Biochem Biophys 2012;64:95–9.
[53]
Lowenstein L, Fitz A, Kenton K, FitzGerald MP, Mueller ER, Brubaker L. Transabdominal uterosacral suspension: outcomes and compli- cations. Am J Obstet Gynecol 2009;200:656.e1–5.
[54]
Crigler B, Zakaria M, Hart S. Total laparoscopic hysterectomy with laparoscopic uterosacral ligament suspension for the treatment of apical pelvic organ prolapse. Surg Technol Int 2012;22:195–202.
[55]
Jeon MJ, Jung HJ, Choi HJ, Kim SK, Bai SW. Is hysterectomy or the use of graft necessary for the reconstructive surgery for uterine pro- lapse? Int Urogynecol J 2008;19:351–5.[56]
Amid PK. Classification of biomaterials and their related complica- tions in abdominal wall hernia surgery. Hernia 1997;1:15–21.
[57]
Jones R, Abrams P, Hilton P, Ward K, Drake M. Risk of tape-related complications after TVT is at least 4%. Neurourol Urodyn 2010;29:40–1.[58]
Abrams P, Shearer K. The MASTER trial: artificial urinary sphincter versus male sling. Trends Urol Mens Health 2015;6:37–8.
[59]
Slack M, Ostergard D, Cervigni M, Deprest J. A standardized de- scription of graft-containing meshes and recommended steps be- fore the introduction of medical devices for prolapse surgery. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstruc- tive surgery. Int Urogynecol J 2012;23(Suppl 1):S15–26.
[60]
Davila GW, Baessler K, Cosson M, Cardozo L. Selection of patients in whom vaginal graft use may be appropriate. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int Urogy- necol J 2012;23(Suppl 1):S7–14.E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 4 2 4 – 4 3 1
431